ClinicalTrials.gg
Sign In

Vulvar Lichen Sclerosus clinical trials

The registry lists 33 studies for Vulvar Lichen Sclerosus across more than 10 countries. 10 are recruiting or about to start. 29 of them are mainly about Vulvar Lichen Sclerosus (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-02.

Get an email when these change. Save the Vulvar Lichen Sclerosus studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
18
Recruiting
6
Not yet recruiting
4
Terminated
3
Status unknown
1
Withdrawn
1

Phase

Phase 2
10
Phase 3
4
Phase 1
3
Phase 4
1

Where

United States
13
Brazil
3
Switzerland
2
China
2
Denmark
2
Russian Federation
1

Who runs them

Medstar Health Research Institute (2) · Center for Vulvovaginal Disorders (2) · University of Texas Southwestern Medical Center (2) · Fundación Eduardo Anitua (1) · 1st Federal Budgetary Healthcare Institution Volga District Medical Center (1) · Daniela de Fátima Teixeira da Silva (1) · Deana Funaro (1) · University of South Alabama (1)

What is being tested here

Drugs under test in Vulvar Lichen Sclerosus studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Platelet rich plasma103
Nemolizumab101
Testosterone111
Methotrexate101
Clobetasol012
Tacrolimus001
Progesterone001
Aminolevulinic Acid001

Coming up

1phase 3 study under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 6 Vulvar Lichen Sclerosus studies recruiting now, 4 (67%) set no upper age limit and 2 (33%) stop at 75 or younger. 0 (0%) take children under 18. 6 (100%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
100 (0%)0 (0%)
185 (83%)0 (0%)
306 (100%)0 (0%)
406 (100%)0 (0%)
505 (83%)0 (0%)
654 (67%)0 (0%)
754 (67%)0 (0%)
854 (67%)0 (0%)

Across all 33 studies, recruiting or not: 15% stop at 75 or younger and 9% at 65; 9% take children; 100% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 33 of 33. search them.